JULIE EDDY: Open Payments
NPI 1578260105 · CARLISLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,871 in 89 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $1,871
Food & beverage: $1,782Education: $89
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $588 |
| ABBVIE INC. | 15 | $285 |
| Regeneron Healthcare Solutions, Inc. | 3 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $147 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $134 |
| Madrigal Pharmaceuticals | 2 | $92 |
| Exact Sciences Corporation | 4 | $85 |
| Ardelyx, Inc. | 4 | $82 |
| Lilly USA, LLC | 3 | $64 |
| GENZYME CORPORATION | 3 | $60 |
Products named: TREMFYA, RINVOQ, XIFAXAN, DUPIXENT, ENTYVIO, REZDIFFRA, IBSRELA, OMVOH.
Industry payments across PA — which companies pay providers there.
